Did the reporting of prognostic studies of tumour markers improve since the introduction of REMARK guideline? A comparison of reporting in published articles
Although biomarkers are perceived as highly relevant for future clinical practice, few biomarkers reach clinical utility for several reasons. Among them, poor reporting of studies is one of the major problems. To aid improvement, reporting guidelines like REMARK for tumour marker prognostic (TMP) st...
Үндсэн зохиолчид: | Sekula, P, Mallett, S, Altman, D, Sauerbrei, W |
---|---|
Формат: | Journal article |
Хэвлэсэн: |
Public Library of Science
2017
|
Ижил төстэй зүйлс
-
Did the reporting of prognostic studies of tumour markers improve since the introduction of REMARK guideline? A comparison of reporting in published articles.
-н: Peggy Sekula, зэрэг
Хэвлэсэн: (2017-01-01) -
Reporting of prognostic studies of tumour markers: a review of published articles in relation to REMARK guidelines
-н: Mallett, S, зэрэг
Хэвлэсэн: (2010) -
Reporting of prognostic studies of tumour markers: a review of published articles in relation to REMARK guidelines.
-н: Mallett, S, зэрэг
Хэвлэсэн: (2010) -
REporting recommendations for tumour MARKer prognostic studies (REMARK).
-н: McShane, L, зэрэг
Хэвлэсэн: (2005) -
Reporting recommendations for tumor marker prognostic studies (REMARK).
-н: McShane, L, зэрэг
Хэвлэсэн: (2005)